Standard

Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh. / Lepekha, L. N.; Lovacheva, O. V.; Chernichenko, N. V.; Erokhin, V. V.; Seiliev, A. A.; Volchkov, V. A.; Rozenberg, O. A.

In: Problemy tuberkuleza i boleznei legkikh, No. 12, 2003, p. 17-21.

Research output: Contribution to journal › Article › peer-review

Harvard

Lepekha, LN, Lovacheva, OV, Chernichenko, NV, Erokhin, VV, Seiliev, AA, Volchkov, VA & Rozenberg, OA 2003, 'Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh.', Problemy tuberkuleza i boleznei legkikh, no. 12, pp. 17-21.

APA

Lepekha, L. N., Lovacheva, O. V., Chernichenko, N. V., Erokhin, V. V., Seiliev, A. A., Volchkov, V. A., & Rozenberg, O. A. (2003). Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh. Problemy tuberkuleza i boleznei legkikh, (12), 17-21.

Vancouver

Lepekha LN, Lovacheva OV, Chernichenko NV, Erokhin VV, Seiliev AA, Volchkov VA et al. Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh. Problemy tuberkuleza i boleznei legkikh. 2003;(12):17-21.

Author

Lepekha, L. N. ; Lovacheva, O. V. ; Chernichenko, N. V. ; Erokhin, V. V. ; Seiliev, A. A. ; Volchkov, V. A. ; Rozenberg, O. A. / Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh. In: Problemy tuberkuleza i boleznei legkikh. 2003 ; No. 12. pp. 17-21.

BibTeX

@article{8b1df3cf79e54ae3aa7d4b47a0535637,
title = "Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh.",
abstract = "The macrophageal elements (ME) of bronchoalveolar lavage were cytologically and electron microscopically studied in 11 patients with active pulmonary tuberculosis who took antituberculous drugs during 3-6 months, which did not yield a significant clinical effect (Group 1) and in 24 patients with the disease who received inhaled C-BL during chemotherapy (Group 2). The drug was administered in a dose of 20 mg by a nebulizer every second day during 4-9 weeks. In Group 1, the high levels of young biosynthesizing (32.08 +/- 0.10) and mature secreting (11.50 +/- 0.70) ME were combined with the lower counts of phagocytizing macrophages (11.50 +/- 0.90). In Group 2, the specific features depended on the duration of C-BL use and after 20-28 inhalations their composition tended to normalize: biosynthesizing (18.30 +/- 1.05), secreting (5.80 +/- 0.95), and phagocytizing (47.20 +/- 1.05). In 19 patients from Group 2, the therapeutic effect was clinically regarded as positive.",
author = "Lepekha, {L. N.} and Lovacheva, {O. V.} and Chernichenko, {N. V.} and Erokhin, {V. V.} and Seiliev, {A. A.} and Volchkov, {V. A.} and Rozenberg, {O. A.}",
year = "2003",
language = "русский",
pages = "17--21",
journal = "ПРОБЛЕМЫ ТУБЕРКУЛЕЗА И БОЛЕЗНЕЙ ЛЕГКИХ",
issn = "1728-2993",
publisher = "Медицина",
number = "12",

}

RIS

TY - JOUR

T1 - Osobennosti makrofagal'noi formuly bronkhoal'veoliarnogo smyva u bol'nykh destruktivnym tuberkulezom legkikh.

AU - Lepekha, L. N.

AU - Lovacheva, O. V.

AU - Chernichenko, N. V.

AU - Erokhin, V. V.

AU - Seiliev, A. A.

AU - Volchkov, V. A.

AU - Rozenberg, O. A.

PY - 2003

Y1 - 2003

N2 - The macrophageal elements (ME) of bronchoalveolar lavage were cytologically and electron microscopically studied in 11 patients with active pulmonary tuberculosis who took antituberculous drugs during 3-6 months, which did not yield a significant clinical effect (Group 1) and in 24 patients with the disease who received inhaled C-BL during chemotherapy (Group 2). The drug was administered in a dose of 20 mg by a nebulizer every second day during 4-9 weeks. In Group 1, the high levels of young biosynthesizing (32.08 +/- 0.10) and mature secreting (11.50 +/- 0.70) ME were combined with the lower counts of phagocytizing macrophages (11.50 +/- 0.90). In Group 2, the specific features depended on the duration of C-BL use and after 20-28 inhalations their composition tended to normalize: biosynthesizing (18.30 +/- 1.05), secreting (5.80 +/- 0.95), and phagocytizing (47.20 +/- 1.05). In 19 patients from Group 2, the therapeutic effect was clinically regarded as positive.

AB - The macrophageal elements (ME) of bronchoalveolar lavage were cytologically and electron microscopically studied in 11 patients with active pulmonary tuberculosis who took antituberculous drugs during 3-6 months, which did not yield a significant clinical effect (Group 1) and in 24 patients with the disease who received inhaled C-BL during chemotherapy (Group 2). The drug was administered in a dose of 20 mg by a nebulizer every second day during 4-9 weeks. In Group 1, the high levels of young biosynthesizing (32.08 +/- 0.10) and mature secreting (11.50 +/- 0.70) ME were combined with the lower counts of phagocytizing macrophages (11.50 +/- 0.90). In Group 2, the specific features depended on the duration of C-BL use and after 20-28 inhalations their composition tended to normalize: biosynthesizing (18.30 +/- 1.05), secreting (5.80 +/- 0.95), and phagocytizing (47.20 +/- 1.05). In 19 patients from Group 2, the therapeutic effect was clinically regarded as positive.

UR - http://www.scopus.com/inward/record.url?scp=84921703812&partnerID=8YFLogxK

M3 - статья

C2 - 15004966

AN - SCOPUS:84921703812

SP - 17

EP - 21

JO - ПРОБЛЕМЫ ТУБЕРКУЛЕЗА И БОЛЕЗНЕЙ ЛЕГКИХ

JF - ПРОБЛЕМЫ ТУБЕРКУЛЕЗА И БОЛЕЗНЕЙ ЛЕГКИХ

SN - 1728-2993

IS - 12

ER -

ID: 85031581